State

New York product recalls

73,741 recalls have nationwide distribution and so reach New York. 12,955 additional recalls listed New York specifically in their distribution scope.

What the numbers show

Total: 12,955
Critical: 1,508
Severe: 3,701
Most recent: 2026-10-28

Of the 12,955 recalls naming New York we have scored against our rubric, 1,508 (12%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3,701 (29%) are Severe.

Which agencies issued them

These figures cover only the 12,955 recalls whose distribution notice names New York specifically. The 73,741 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

38226–38250 of 86696

SevereFDA (Drugs)·D-1637-2019·2019-08-14
RXQ Compounding Recalls Avastin Syringes Due to Sterility Concerns
RXQ Compounding LLC is recalling Avastin 25mg/mL syringes because the company cannot ensure the product is sterile. The recall covers all lots within their expiration dates.
Product
Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1641-2019·2019-08-14
RXQ Compounding Recalls Calcium Chloride Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Calcium Chloride 100mg/mL Injection Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
CALCIUM CHLORIDE 100MG/ML (PFV) INJ SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0920-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1699-2019·2019-08-14
RXQ Compounding Recalls Pyridoxine Vials Due to Sterility Concerns
RXQ Compounding LLC is recalling Pyridoxine (MDV) 100mg/mL vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0956-30
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1705-2019·2019-08-14
RXQ Compounding Recalls Lidocaine Syringes Due to Sterility Concerns
RXQ Compounding LLC is recalling Lidocaine 0.75%/Epinephrine 0.025% syringes because the FDA determined there is a lack of assurance of sterility.
Product
LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR, 1 ML PER Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0919-01
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1682-2019·2019-08-14
RXQ Compounding Recalls Midazolam Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Midazolam 1mg/mL injection syringes because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-86
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1651-2019·2019-08-14
RXQ Compounding Recalls EDETATE DISODIUM 30% INJECTABLE Due to Sterility Concerns
RXQ Compounding LLC is recalling EDETATE DISODIUM 30% INJECTABLE, 100 ML vials, because the product lacks assurance of sterility.
Product
EDETATE DISODIUM 30% INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0931-11
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1662-2019·2019-08-14
RXQ Compounding Recalls Glutathione Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Glutathione 200mg/ml Injection Solution because the product lacks assurance of sterility. All lots within expiry are affected nationwide.
Product
GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0971-81
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1714-2019·2019-08-14
RXQ Compounding Recalls TURBO DROPS Ophthalmic Solution Due to Sterility Concerns
RXQ Compounding LLC is recalling TURBO DROPS ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
TURBO DROPS (PHEN 10% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0206-05
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1667-2019·2019-08-14
RXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
RXQ Compounding LLC is recalling Hydroxocobalamin 1000 mcg/mL injections because the product lacks assurance of sterility.
Product
HYDROXOCOBALAMIN 1000 MCG/ML (MDV), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0926-30
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Devices)·Z-2204-2019·2019-08-14
Ad-Tech Recalls Non-Sterile Anchor Bolts for Depth Electrodes
Ad-Tech Medical Instrument Corporation is recalling 201 non-sterile anchor bolts distributed without regulatory clearance or validated sterilization instructions.
Product
LSB Style Anchor Bolt. Labeled with the following parts: 13mm anodized anchor bolt body with anchor bolt cap containing a blue gasket and silicone cap, 21mm anodized anchor bolt body with anchor bolt cap containing a blue gasket and silicone cap, 13mm non-anodized anchor…
Category
Medical Device
Distribution
Distributed nationwide
SevereNHTSA·19V593000·2019-08-14
BMW Recalls G310R, G310 GS, and C 400 X for Brake Caliper Defect
BMW is recalling 2017-2020 G310R, 2018-2020 G310 GS, and 2019 C 400 X motorcycles because brake caliper pistons may corrode and stick, increasing crash risk.
Product
BMW — BMW G310R, G310 GS, C 400 X
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1650-2019·2019-08-14
RXQ Compounding Recalls EDETATE CALCIUM DISODIUM INJECTABLE Due to Sterility Concerns
RXQ Compounding LLC is recalling EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE vials because the product lacks assurance of sterility.
Product
EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0934-11
Category
Drug
Distribution
Distributed nationwide
SevereNHTSA·19V601000·2019-08-14
BMW and MINI Recall Vehicles Due to Steering Tie Rod Defect
BMW is recalling 2018-2019 X1, X2, and MINI Cooper models because incorrectly assembled steering tie rods may break, causing loss of vehicle control.
Product
BMW — BMW, MINI X1, X2, COOPER
Category
Vehicle
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1646-2019·2019-08-14
RXQ Compounding Recalls Dextrose 50% Injection Syringes Due to Sterility Concerns
RXQ Compounding LLC is recalling Dextrose 50% Injection Solution syringes because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1640-2019·2019-08-14
RXQ Compounding Recalls Buffered Lidocaine HCL 1% Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Buffered Lidocaine HCL 1% Injection Solution because the product lacks assurance of sterility.
Product
BUFFERED LIDOCAINE HCL 1% INJECTION SOL (PF) SYR, 0.5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0139-84
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1672-2019·2019-08-14
RXQ Compounding Recalls Lidocaine HCL 2% Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Lidocaine HCL 2% Injection Solution because the product lacks assurance of sterility. The recall covers all lots within their expiry dates.
Product
LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0172-20
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1710-2019·2019-08-14
RXQ Compounding Recalls Thiamine HCL Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Thiamine HCL 100mg/mL Injection because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
THIAMINE HCL 100MG/ML (MDV) INJECTION, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0950-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1647-2019·2019-08-14
RXQ Compounding Recalls Dextrose 50% Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Dextrose 50% Injection Solution vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
DEXTROSE 50% INJECTION SOLUTION (PF) VIAL, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1676-2019·2019-08-14
RXQ Compounding Recalls Manganese Sulfate Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Manganese Sulfate Monohydrate Injection because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0952-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1694-2019·2019-08-14
RXQ Compounding Recalls Potassium Chloride Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Potassium Chloride 15% Injection Solution due to a lack of assurance of sterility. The recall covers all lots within expiry distributed nationwide.
Product
POTASSIUM CHLORIDE 15% (2MEQ/ML) INJ SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0954-30
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1657-2019·2019-08-14
RXQ Compounding Recalls Epinephrine Syringes Due to Sterility Concerns
RXQ Compounding LLC is recalling Epinephrine 1:1000 Injection Solution syringes because the company cannot ensure the product is sterile.
Product
EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0947-01
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Devices)·Z-2168-2019·2019-08-14
Centurion Medical Recalls High Drainage LVAD Tray Kits Due to Packaging Concerns
Centurion Medical Products Corporation is recalling 192 High Drainage LVAD Tray Kits because sterile packaging may be compromised.
Product
HIGH DRAINAGE LVAD TRAY Kit Code: DM950 - Product Usage: Kit is used for Driveline Maintenance and Securement of Line for general patient population.
Category
Medical Device
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1685-2019·2019-08-14
RXQ Compounding Recalls Molybdenum Injection Solution Due to Sterility Concerns
RXQ Compounding LLC is recalling Molybdenum 0.025mg/mL Injection Solution because the product lacks assurance of sterility.
Product
MOLYBDENUM 0.025MG/ML INJECTION SOLUTION, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0964-10
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1656-2019·2019-08-14
RXQ Compounding Recalls Epinephrine Infusion Bags Due to Sterility Concerns
RXQ Compounding LLC is recalling Epinephrine 4mg in D5W 5% infusion bags because the agency could not ensure the product was sterile.
Product
EPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0113-22
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-1718-2019·2019-08-14
RXQ Compounding Recalls Zinc Sulfate Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling Zinc Sulfate 1mg/mL Injection Solution because the product lacks assurance of sterility.
Product
ZINC SULFATE 1MG/ML INJECTION SOLUTION (PFV), 10ML per VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0963-10
Category
Drug
Distribution
Distributed nationwide